Skip to main content
SpringerLink
Log in

The role of protein kinase C in multidrug resistance

  • Chapter
Anticancer Drug Resistance

Part of the book series: Cancer Treatment and Research ((CTAR,volume 73))

Abstract

The development of resistance to anticancer agents during treatment is a major obstacle to successful cancer therapy [1–3]. In addition, certain tumor cells exhibit de novo resistance to anticancer agents. De novo resistance is commonly observed in renal, gastric, and colon cancers, and it precludes successful treatment of these diseases with chemotherapeutic drugs [2]. Cultured tumor cell populations often acquire a multidrug resistance (MDR) phenotype after prolonged exposure to cytotoxic natural products such as anthracyclines, vinca alkaloids, and epipodophyllotoxins [1–3]. MDR tumor cells are by definition resistant to the cytotoxic effects of the selecting agent and cross-resistant to cytotoxic natural products that are structurally diverse but generally have in common the ability to produce MDR tumor cells from drug-sensitive tumor cell populations [1-3]. Patterns of cross-resistance observed among different MDR tumor cell lines are variable and unpredictable. Because many of the cytotoxic natural products linked to the MDR phenotype are anticancer agents [1–3], it is believed that an understanding of the MDR phenotype could potentially lead to significant improvements in cancer theraphy [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Endicott, J.A. and Ling, V. 1989. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu. Rev. Biochem. 58: 137–171.

    Article  PubMed  CAS  Google Scholar 

  2. Tsuruo, T. 1988. Mechanisms of multidrug resistance and implications for therapy. Jpn. J. Cancer. Res. 79: 285–296.

    Article  PubMed  CAS  Google Scholar 

  3. Moscow, J.A. and Cowan, K.H. 1988. Multidrug resistance. J. Natl. Cancer Inst. 80: 14–20.

    Article  PubMed  CAS  Google Scholar 

  4. Fojo, A.T., Ueda, K., Slamon, D.J., Poplack, D.G., Gottesman, M.M., and Pastan, I. 1987. Expression of a multidrug-resistance gene in human tumors and tissues. Proc. Natl. Acad. Sci. 84: 265–269.

    Article  PubMed  CAS  Google Scholar 

  5. Goldstein, L.J., Galski, H., Fojo, A., Willingham, M., Lai, S.-L., Gazdar, A., Pirker, R., Green, A., Crist, W., Brodeur, G.M., Lieber, M., Cossman, J., Gottesman, M.M., and Pastan, I. 1989. Expression of a multidrug resistance gene in human cancers. J. Natl. Cancer Inst. 81: 116–124.

    Article  PubMed  CAS  Google Scholar 

  6. Bradley, G., Sharma, R., Rajalakshmi, S., and Ling, V. 1992. P-glycoprotein expression during tumor progression in the rat liver. Cancer Res. 52: 5154–5161.

    PubMed  CAS  Google Scholar 

  7. Weinstein, R.S., Jakate, S.M., Dominguez, J.M., Lebovitz, M.D., Koukoulis, G.K., Kuszak, J.R., Klusens, L.F., Grogan, T.M., Saclarides, T.J., Roninson, I.B., and Coon, J.S. 1991. Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. Cancer Res. 51: 2720–2726.

    PubMed  CAS  Google Scholar 

  8. Chan, H.S.L., Thorner, P.S., Haddad, G., and Ling, V. 1990. Immunohistochemical detection of P-glycoprotein: Prognostic correlation in soft tissue sarcoma of childhood. J. Clin. Oncol. 8: 689–704.

    PubMed  CAS  Google Scholar 

  9. O’Brian, C.A. and Ward, N.E. 1989. Biology of the protein kinase C family. Cancer Metastasis Rev. 8: 199–214.

    Article  Google Scholar 

  10. Bell, R.M. and Burns, D.J. 1991. Lipid activation of protein kinase C. J. Biol. Chem. 266: 4661–4664.

    PubMed  CAS  Google Scholar 

  11. O’Brian, CA., Fan, D., Ward, N.E., Seid, C., and Fidler, I.J. 1989. Level of protein kinase C activity correlates directly with resistance to Adriamycin in murine fibrosarcoma cells. FEBS Letts. 246: 78–82.

    Article  Google Scholar 

  12. Fine, R.L., Patel, J., and Chabner, B.A. 1988. Phorbol esters induce multidrug resistance in human breast cancer cells. Proc. Natl. Acad. Sci. USA 85: 582–586.

    Article  PubMed  CAS  Google Scholar 

  13. Palayoor, S.T., Stein, J.M., and Hait, W.N. 1987. Inhibition of protein kinase C by antineoplastic agents: Implications for drug resistance. Biochem. Biophys. Res. Commun. 148: 718–725.

    CAS  Google Scholar 

  14. Posada, J.A., McKeegan, E.M., Worthington, K.F., Morin, M.J., Jaken, S., and Tritton, T.R. 1989. Human multidrug resistant KB cells overexpress protein kinase C: Involvement in drug resistance. Cancer Commun. 1: 285–292.

    PubMed  CAS  Google Scholar 

  15. Aquino, A., Hartman, K.D., Knode, M.C., Grant, S., Huang, K.-P., Niu, C.-H., and Glazer, RI. 1988. Role of protein kinase C in phosphorylation of vinculin in Adriamycin-resistant HL-60 leukemia cells. Cancer Res. 48: 3324–3329.

    PubMed  CAS  Google Scholar 

  16. Chambers, T.C., McAvoy, E.M., Jacobs, J.W., and Eilon, G. 1990. Protein kinase C phosphorylates P-glycoprotein in multidrug resistant human KB carcinoma cells. J. Biol. Chem. 265: 7679–7686.

    PubMed  CAS  Google Scholar 

  17. Schwartz, G.K., Arkin, H., Holland, J.F., and Ohnuma, T. 1991. Protein kinase C activity and multidrug resistance in MOLT-3 human lymphoblastic leukemia cells resistant to trimetrexate. Cancer Res. 51: 55–61.

    PubMed  CAS  Google Scholar 

  18. Ido, M., Sato, K., Sakurai, M., Inagaki, M., Saitoh, M., Watanabe, M., and Hidaka, H. 1987. Decreased phorbol ester receptor and protein kinase C in P388 murine leukemic cells resistant to etoposide. Cancer Res. 47: 3460–3463.

    PubMed  CAS  Google Scholar 

  19. Ido, M., Asao, T., Sakurai, M., Inagaki, M., Saito, M., and Hidaka, H. 1986. An inhibitor of protein kinase C, l-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H7) inhibits TPA-induced reduction of vincristine uptake from P388 murine leukemic cell. Leukemia Res. 10: 1063–1069.

    Article  CAS  Google Scholar 

  20. Lee, S.A., Karaszkiewicz, J.W., and Anderson, W.B. 1992. Elevated level of nuclear protein kinase C in multidrug-resistant MCF-7 human breast carcinoma cells. Cancer Res. 52: 3750–3759.

    PubMed  CAS  Google Scholar 

  21. Posada, J., Vichi, P., and Tritton, TR. 1989. Protein kinase C in Adriamycin action and resistance in mouse sarcoma 180 cells. Cancer Res. 49: 6634–6639.

    PubMed  CAS  Google Scholar 

  22. O’Brian, CA., Fan, D., Ward, N.E., Dong, Z., Iwamoto, L., Gupta, K.P., Earnest, L.E., and Fidler, I.J. 1991. Transient enhancement of multidrug resistance by the bile acid deoxycholate in murine fibrosarcoma cells in vitro. Biochem. Pharmacol. 41: 797–806.

    Article  Google Scholar 

  23. Ward, N.E. and O’Brian, C.A. 1991. Distinct patterns of phorbol ester-induced down-regulation of protein kinase C activity in Adriamycin-selected multidrug resistant and parental murine fibrosarcoma cells. Cancer Lett. 58: 189–193.

    Article  PubMed  CAS  Google Scholar 

  24. Blobe, G.C., Sachs, C.W., Khan, W.A., Fabbro, D., Stabel, S., Wetsel, W.C., Obeid, L.M., Fine, R.L., and Hannun, Y.A. 1993. Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF7 cells. J. Biol. Chem. 268: 658–664.

    PubMed  CAS  Google Scholar 

  25. Aquino, A., Warren, B.S., Omichinski, J., Hartman, K.D., and Glazer, R.I. 1990. Protein kinase C-γ is present in Adriamycin-resistant HL-60 leukemia cells. Biochem. Biophys. Res. Commun. 166: 723–728.

    CAS  Google Scholar 

  26. Efferth, T. and Volm, M. 1992. Expression of protein kinase C in human renal cell carcinoma cells with inherent resistance to doxorubicin. Anticancer Res. 12: 2209–2212.

    PubMed  CAS  Google Scholar 

  27. Chambers, T.C., Chalikonda, I., and Eilon, G. 1990. Correlation of protein kinase C trans-location, P-glycoprotein phosphorylation and reduced drug accumulation in multidrug resistant human KB cells. Biochem. Biophys. Res. Commun. 169: 253–259.

    CAS  Google Scholar 

  28. Dong, Z., Ward, N.E., Fan, D., Gupta, K.P., and O’Brian, C.A. 1991. In vitro model for intrinsic drug resistance: Effects of protein kinase C activators on the chemosensitivity of cultured human colon cancer cells. Mol. Pharmacol. 39: 563–569.

    PubMed  CAS  Google Scholar 

  29. Ferguson, P.J. and Cheng, Y. 1987. Transient protection of cultured human cells against antitumor agents by 12-0-tetradecanoylphorbol-13-acetate. Cancer Res. 47: 433–441.

    PubMed  CAS  Google Scholar 

  30. Nygren, P. and Larsson, R. 1990. Modulation of vincristine sensitivity of human kidney tumor cells by pharmacological agents interfering with intracellular signals. No apparent relationship to changes in cytoplasmic Ca2+ or pH. Biochim. Biophys. Acta 1052: 392–398.

    Article  CAS  Google Scholar 

  31. Kessel, D. 1988. Effects of phorbol esters on doxorubicin transport systems. Biochem. Pharmacol. 37: 2297–2299.

    Article  PubMed  CAS  Google Scholar 

  32. Yu, G., Ahmad, S., Aquino, A., Fairchild, C.R., Trepel, J.B., Ohno, S., Suzuki, K., Tsuruo, T., Cowan, K.H., and Glazer, R.I. 1991. Transfection with protein kinase Cα confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein. Cancer Commun. 3: 181–189.

    PubMed  CAS  Google Scholar 

  33. Fan, D., Fidler, I.J., Ward, N.E., Seid, C., Earnest, L.E., Housey, G.M., and O’Brian, C.A. 1992. Stable expression of a cDNA encoding rat brain protein kinase C-ß, confers a multidrug-resistant phenotype on rat fibroblasts. Anticancer Res. 12: 661–668.

    PubMed  CAS  Google Scholar 

  34. Qian, X. and Beck, W.T. 1990. Binding of an optically pure photoaffinity analogue of verapamil, LU-49888, to P-glycoprotein from multidrug-resistant human leukemic cell lines. Cancer Res. 50: 1132–1137.

    PubMed  CAS  Google Scholar 

  35. Yusa, K. and Tsuruo, T. 1989. Reversal mechanism of multidrug resistance by verapamil: Direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells. Cancer Res. 49: 5002–5006.

    PubMed  CAS  Google Scholar 

  36. Hidaka, H., Inagaki, M., Kawamoto, S., and Sasaki, Y., 1984. Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23: 5036–5041.

    Article  PubMed  CAS  Google Scholar 

  37. O’Brian, CA., Ward, N.E., Liskamp, R.M., de Bont, D.B., Earnest, L.E., van Boom, J.H., and Fan, D. 1991. A novel, N-myristylated synthetic octapeptide inhibits protein kinase C activity and partially reverses murine fibrosarcoma cell resistance to Adriamycin. Invest. New Drugs 9: 169–179.

    Google Scholar 

  38. O’Brian, C.A. and Ward, N.E. 1990. Staurosporine: A prototype of a novel class of inhibitors of tumor cell invasion? J. Natl. Cancer Inst. 82: 1734–1735.

    Article  Google Scholar 

  39. Mori, T., Takai, Y., Minakuchi, R., Yu, B., and Nishizuka, Y. 1980. Inhibitory action of chlorpromazine, dibucaine, and other phospholipid-interacting drugs on calcium-activated, phospholipid-dependent protein kinase. J. Biol. Chem. 255: 8378–8380.

    PubMed  CAS  Google Scholar 

  40. Hagiwara, M., Wakusawa, S., Miyamoto, K.I., and Hidaka, H. 1991. Obviation of drug resistance and affinity purification of P-glycoprotein by isoquinolinesulfonamides. Cancer Lett. 60: 103–107.

    Article  PubMed  CAS  Google Scholar 

  41. Miyamoto, K.I., Inoko, K., Ikeda, K., Wakusawa, S., Kajita, S., Hasegawa, T., Takagi, K., and Koyama, M. 1993. Effect of staurosporine derivatives on protein kinase activity and vinblastine accumulation in mouse leukemia P388/ADR cells. J. Pharm. Pharmacol. 45: 43–47.

    CAS  Google Scholar 

  42. O’Brian, CA., Liskamp, R.M., Solomon, D.H., and Weinstein, I.B. 1985. Inhibition of protein kinase C by tamoxifen. Cancer Res. 45: 2462–2465.

    Google Scholar 

  43. Su, H.-D., Mazzei, G.J., Vogler, W.R., and Kuo, J.F. 1985. Effect of tamoxifen, a nonsteroidal antiestrogen, on phospholipid/calcium-dependent protein kinase and phosphorylation of its endogenous substrate proteins from the rat brain and ovary. Biochem. Pharmacol. 34: 3649–3653.

    Article  PubMed  CAS  Google Scholar 

  44. O’Brian, C.A., Ward, N.E., and Anderson, B.W. 1988. Role of specific interactions between protein kinase C and triphenylethylenes in inhibition of the enzyme. J. Natl. Cancer Inst. 80: 1628–1633.

    Article  Google Scholar 

  45. Akiyama, S., Shiraishi, N., Kuratomi, Y., Nakagawa, M., and Kuwano, M. 1986. Circumvention of multiple-drug resistance in human cancer cells by thioridazine, trifluoperazine, and chlorpromazine. J. Natl. Cancer Inst. 76: 839–844.

    PubMed  CAS  Google Scholar 

  46. Wise, B.C., Glass, D.B., Chou, C.H.J., Raynor, R.L., Katoh, N., Schatzman, R.C., Turner, R.S., Kibler, R.F., and Kuo, J.F. 1982. Phospholipid-sensitive Ca2+-dependent protein kinase from heart. J. Biol. Chem. 257: 8489–8495.

    PubMed  CAS  Google Scholar 

  47. Hait, W.N. and Pierson, N.R. 1990. Comparison of the efficacy of a phenothiazine and a bisquinaldinium calmodulin antagonist against multidrug-resistant P388 cell lines. Cancer Res. 50: 1165–1169.

    PubMed  CAS  Google Scholar 

  48. Weisenthal, L.M., Su, Y.-Z., Duarte, T.E., Dill, P.L., and Nagourney, R.A. 1987. Perturbation of in vitro drug resistance in human lymphatic neoplasms by combinations of putative inhibitors of protein kinase C. Cancer Treat. Rep. 71: 1239–1243.

    PubMed  CAS  Google Scholar 

  49. Chatterjee, M. and Harris, A.L. 1990. Reversal of acquired resistance to Adriamycin in CHO cells by tamoxifen and 4-hydroxy tamoxifen: Role of drug interaction with alpha 1 acid glycoprotein. Br. J. Cancer 62: 712–717.

    Article  PubMed  CAS  Google Scholar 

  50. Mellado, W. and Horwitz, S.B. 1987. Phosphorylation of the multidrug resistance associated glycoprotein. Biochemistry 26: 6900–6904.

    Article  PubMed  CAS  Google Scholar 

  51. Staats, J., Marquardt, D., and Center, M.S. 1990. Characterization of a membrane-associated protein kinase of multidrug-resistant HL60 cells which phosphorylates P-glycoprotein. J. Biol. Chem. 265: 4084–4090.

    PubMed  CAS  Google Scholar 

  52. Hamada, H. and Tsuruo, T. 1988. Characterization of the ATPase activity of the Mr 170,000 to 180,000 membrane glycoprotein (P-glycoprotein) associated with multidrug resistance in K562/ADM cells. Cancer Res. 48: 4926–4932.

    PubMed  CAS  Google Scholar 

  53. Safa, A.R., Glover, C.J., Meyers, M.B., Biedler, J.L., and Felsted, R.L. 1986. Vinblastine photoaffinity labeling of a high molecular weight surface membrane glycoprotein specific for multidrug-resistant cells. J. Biol. Chem. 261: 6137–6140.

    PubMed  CAS  Google Scholar 

  54. Hamada, H., Hagiwara, K.-I., Nakajima, T., and Tsuruo, T. 1987. Phosphorylation of the Mr 170,000 to 180,000 glycoprotein specific to multidrug-resistant tumor cells: Effects of verapamil, trifluoperazine, and phorbol esters. Cancer Res. 47: 2860–2865.

    PubMed  CAS  Google Scholar 

  55. Chambers, T.C., Pohl, J., Raynor, R.L., and Kuo, J.F. 1993. Identification of specific sites in human P-glycoprotein phosphorylated by protein kinase C. J. Biol. Chem. 268: 4592–4595.

    PubMed  CAS  Google Scholar 

  56. Werth, D.K., Niedel, J.E., and Pastan, I. 1983. Vinculin, a cytoskeletal substrate of protein kinase C. J. Biol. Chem. 258: 11423–11426.

    PubMed  CAS  Google Scholar 

  57. Epand, R.M. and Stafford, A.R. 1993. Protein kinases and multidrug resistance. Cancer J. 6: 154–157.

    CAS  Google Scholar 

Download references

Authors
  1. Catherine A. O’Brian
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nancy E. Ward
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Karen R. Gravitt
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dominic Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA

    Lori J. Goldstein  & Robert F. Ozols  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media New York

About this chapter

Cite this chapter

O’Brian, C.A., Ward, N.E., Gravitt, K.R., Fan, D. (1994). The role of protein kinase C in multidrug resistance. In: Goldstein, L.J., Ozols, R.F. (eds) Anticancer Drug Resistance. Cancer Treatment and Research, vol 73. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2632-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-2632-2_3

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6129-9

  • Online ISBN: 978-1-4615-2632-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation